title: Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy.
authors.forename: Michele
authors.initials: M
authors.lastname: Cavo
authors.forename: Elena
authors.initials: E
authors.lastname: Zamagni
authors.forename: Claudia
authors.initials: C
authors.lastname: Cellini
authors.forename: Patrizia
authors.initials: P
authors.lastname: Tosi
authors.forename: Delia
authors.initials: D
authors.lastname: Cangini
authors.forename: Michele
authors.initials: M
authors.lastname: Cini
authors.forename: Lelia
authors.initials: L
authors.lastname: Valdrè
authors.forename: Gualtiero
authors.initials: G
authors.lastname: Palareti
authors.forename: Luciano
authors.initials: L
authors.lastname: Masini
authors.forename: Sante
authors.initials: S
authors.lastname: Tura
authors.forename: Michele
authors.initials: M
authors.lastname: Baccarani
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D015994:Incidence; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects; D020246:Venous Thrombosis / Q000139:chemically induced* / Q000473:pathology
chemical_list: D013792:Thalidomide; D003907:Dexamethasone